Managing DIabetes Remission After Combined Therapy in EarLy Stage of DiabetEs
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 108 participants.
Also called NCT04271189
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 108 participants
- Sponsor
- Azienda Ospedaliero-Universitaria di Parma
- Registry
-
NCT04271189
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Italy
- Registry status
- Completed
Technical summary
Registry record NCT04271189. Randomized; no masking; primary purpose treatment. Start 2020-09-01 (actual); primary completion 2024-08-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Managing DIabetes Remission After Combined Therapy in EarLy Stage of DiabetEs
- Acronym
- MIRACLE
- Condition
- Newly Diagnosed Type 2 Diabetes
- Intervention (Drug)
- Metformin-Sitagliptin-Empaglifozin-Pioglitazone
- Intervention (Drug)
- Standard of care
- Lead sponsor
- Azienda Ospedaliero-Universitaria di Parma
Record details
- Record id
cardio:ct-nct04271189- Content hash
ae2c4bf9a8ab47d5b79c5d3d2b591b964198cb97a86e3ee0b0257a15b2fe4d2f